04/05/2011
https://congress.gov...
"I am particularly interested in how the process can be better utilized for rare diseases."
"We all agree that it is important to prevent counterfeit drugs from reaching our Nation's patients."
"Hon. Joseph R. Pitts, a Representative in Congress from the Commonwealth of Pennsylvania, opening statement."
"Despite the success of Accelerated Approval for cancer drugs, I have talked with patients and innovators and investors, and they indicate that some in FDA intend to limit the use of the Accelerated Ap..."